Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. (Q40481644)

20 September 2017

Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. (English)

1 reference

Christine A Iacobuzio-Donahue

20 September 2017

1 reference

series ordinal

5

object named as

Christine A Iacobuzio-Donahue

1 reference

20 September 2017

7

Michael Goggins

1 reference

20 September 2017

3

Noriyoshi Fukushima

1 reference

20 September 2017

6

James R Eshleman

1 reference

20 September 2017

Norihiro Sato

1

1 reference

20 September 2017

Antony R Parker

series ordinal

2

1 reference

20 September 2017

Yohei Miyagi

series ordinal

4

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

20 September 2017

1 reference

20 September 2017

24

1 reference

20 September 2017

5

1 reference

20 September 2017

850-858

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208050

20 September 2017

0 references

cites work

Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Matrix metalloproteinases: a tail of a frog that became a prince

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

The effect of human tissue factor pathway inhibitor-2 on the growth and metastasis of fibrosarcoma tumors in athymic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Invasion and metastasis in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Quantitative GSTP1 Methylation and the Detection of Prostate Adenocarcinoma in Sextant Biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation in choriocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Large-scale allelotype of pancreaticobiliary carcinoma provides quantitative estimates of genome-wide allelic loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

21 January 2018

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

The ERK/MAPK pathway regulates the activity of the human tissue factor pathway inhibitor-2 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Novel extracellular matrix-associated serine proteinase inhibitors from human skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

DNMT1 and DNMT3b cooperate to silence genes in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Tissue factor pathway inhibitor-2 is a novel mitogen for vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Comprehensive analysis of CpG islands in human chromosomes 21 and 22

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Purification, molecular cloning, and expression of a novel growth-promoting factor for retinal pigment epithelial cells, REF-1/TFPI-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

inferred from DOI database lookup

7 January 2021

based on heuristic

The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208050

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1208050

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference